tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

LGND Stock Latest News

Ligand price target raised to $160 from $150 at Barclays
The FlyLigand price target raised to $160 from $150 at Barclays
1M ago
LGND
Ligand price target raised to $143 from $141 at RBC Capital
PremiumThe Fly
Ligand price target raised to $143 from $141 at RBC Capital
1M ago
LGND
Ligand price target raised to $151 from $135 at Oppenheimer
PremiumThe Fly
Ligand price target raised to $151 from $135 at Oppenheimer
1M ago
LGND
Ligand provides updated five-year outlook
PremiumThe Fly
Ligand provides updated five-year outlook
1M ago
LGND
Ligand backs FY24 adjusted EPS view $5.50-$5.70, consensus $5.65
PremiumThe Fly
Ligand backs FY24 adjusted EPS view $5.50-$5.70, consensus $5.65
1M ago
LGND
Ligand sees FY25 EPS $6.00-$6.25, consensus $6.03
PremiumThe FlyLigand sees FY25 EPS $6.00-$6.25, consensus $6.03
1M ago
LGND
Ligand to hold investor and analyst day
Premium
The Fly
Ligand to hold investor and analyst day
1M ago
LGND
Ligand price target raised to $141 from $140 at RBC Capital
Premium
The Fly
Ligand price target raised to $141 from $140 at RBC Capital
2M ago
LGND
Ligand price target raised to $147 from $135 at Oppenheimer
PremiumThe Fly
Ligand price target raised to $147 from $135 at Oppenheimer
2M ago
LGND
Ligand price target raised to $150 from $125 at Barclays
PremiumThe Fly
Ligand price target raised to $150 from $125 at Barclays
2M ago
LGND
Ligand Pharmaceuticals Reports Strong Q3 2024 Growth
PremiumCompany Announcements
Ligand Pharmaceuticals Reports Strong Q3 2024 Growth
2M ago
LGND
Ligand reports Q3 EPS $1.84, consensus $1.35
PremiumThe Fly
Ligand reports Q3 EPS $1.84, consensus $1.35
2M ago
LGND
Ligand raises FY24 EPS view to $5.50-$5.70, consensus $5.39
PremiumThe FlyLigand raises FY24 EPS view to $5.50-$5.70, consensus $5.39
2M ago
LGND
Is LGND a Buy, Before Earnings?
Premium
Pre-Earnings
Is LGND a Buy, Before Earnings?
3M ago
LGND
Ligand price target raised to $125 from $110 at Barclays
Premium
The Fly
Ligand price target raised to $125 from $110 at Barclays
3M ago
LGND
Ligand price target raised to $157 from $144 at H.C. Wainwright
PremiumThe Fly
Ligand price target raised to $157 from $144 at H.C. Wainwright
3M ago
LGND
Palvella Therapeutics apponts Matthew Korenberg as CFO
PremiumThe Fly
Palvella Therapeutics apponts Matthew Korenberg as CFO
3M ago
LGND
PIRS
Tractor Supply downgraded, EVgo upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Tractor Supply downgraded, EVgo upgraded: Wall Street’s top analyst calls
4M ago
ASO
DVN
Ligand initiated with an Outperform at Oppenheimer
PremiumThe Fly
Ligand initiated with an Outperform at Oppenheimer
4M ago
LGND
Ligand management to meet with Craig-Hallum
PremiumThe FlyLigand management to meet with Craig-Hallum
4M ago
LGND
Jefferies biotech analyst holds an analyst/industry conference call
Premium
The Fly
Jefferies biotech analyst holds an analyst/industry conference call
4M ago
LGND
VRNA
Ligand, Travere Therapeutics receives full FDA approval for Filspari
Premium
The Fly
Ligand, Travere Therapeutics receives full FDA approval for Filspari
5M ago
LGND
TVTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >